CVE:NU NeutriSci International (NU) Stock Price, News & Analysis → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free NU Stock Alerts C$0.0050 0.00 (0.00%) (As of 04/24/2024 05:23 PM ET) Add Compare Share Share Today's RangeC$0.01▼C$0.0150-Day RangeC$0.01▼C$0.0152-Week RangeC$0.01▼C$0.02Volume30,000 shsAverage Volume54,573 shsMarket CapitalizationC$892,100.00P/E RatioN/ADividend Yield2.61%Price TargetN/A Stock AnalysisStock AnalysisChartStock AnalysisChart Get NeutriSci International alerts: Email Address Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. About NeutriSci InternationalNeutriSci International Inc. develops and markets nutraceutical products in Canada, Germany, and Japan. It offers neuenergy, an energy tab designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail storefront and online markets. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.Read More NU Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NU Stock News HeadlinesMarch 27, 2023 | marketwatch.comMedical Nebulizer Market Outlook and Forecast till 2031September 22, 2021 | apnews.comNeutriSci Receives Additional Purchase Order and Deposit from Tabletz Distribution PartnerApril 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.September 11, 2021 | apnews.comNeutriSci Arranges Strategic Financing with Tabletz and Exercise of WarrantsSee More Headlines Receive NU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeutriSci International and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/25/2024Next Earnings (Estimated)5/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCVE:NU CUSIPN/A CIKN/A Webwww.neutrisci.com Phone403-264-6320FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-175.93% Debt Debt-to-Equity Ratio20.93 Current Ratio0.02 Quick Ratio0.02 Sales & Book Value Annual SalesC$432,451.00 Price / Sales2.06 Cash FlowC$0.00 per share Price / Cash Flow25.00 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares178,420,000Free FloatN/AMarket CapC$892,100.00 OptionableNot Optionable Beta0.82 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Glen RehmanCEO, President & DirectorMr. John Robert Chisholm (Age 62)Chief Financial Officer Ms. Jaycee WatersOperations & Logistics ManagerMr. Thierry SorhaitzVice President of Sales & MarketingKey CompetitorsSugarBud Craft GrowersCVE:SUGRAvivagenCVE:VIVAequus PharmaceuticalsCVE:AQSRadient TechnologiesCVE:RTIAcerus PharmaceuticalsTSE:ASPView All Competitors NU Stock Analysis - Frequently Asked Questions How have NU shares performed in 2024? NeutriSci International's stock was trading at C$0.01 at the beginning of 2024. Since then, NU stock has increased by 0.0% and is now trading at C$0.01. View the best growth stocks for 2024 here. When is NeutriSci International's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 23rd 2024. View our NU earnings forecast. What other stocks do shareholders of NeutriSci International own? Based on aggregate information from My MarketBeat watchlists, some companies that other NeutriSci International investors own include EMCOR Group (EME), Incyte (INCY), Northwest Pipe (NWPX), UnitedHealth Group (UNH), Watsco (WSO), Zimmer Biomet (ZBH), 3i Infrastructure (3IN), Axos Financial (AX) and Actinium Pharmaceuticals (ATNM). How do I buy shares of NeutriSci International? Shares of NU stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:NU) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsThe World's First "$20 Trillion Drug?"Behind the MarketsThe only accurate crypto trading system I know …Weiss RatingsFed launches fourth dollar overhaulStansberry ResearchForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeutriSci International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
